ES2065911T3 - Produccion de proteinas en formas activas. - Google Patents

Produccion de proteinas en formas activas.

Info

Publication number
ES2065911T3
ES2065911T3 ES88305404T ES88305404T ES2065911T3 ES 2065911 T3 ES2065911 T3 ES 2065911T3 ES 88305404 T ES88305404 T ES 88305404T ES 88305404 T ES88305404 T ES 88305404T ES 2065911 T3 ES2065911 T3 ES 2065911T3
Authority
ES
Spain
Prior art keywords
protein production
active forms
host cells
proteins
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88305404T
Other languages
English (en)
Inventor
Joseph John Patroni
Malcolm Roy Brandon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Cross Biotech Pty Ltd
Original Assignee
Southern Cross Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Cross Biotech Pty Ltd filed Critical Southern Cross Biotech Pty Ltd
Application granted granted Critical
Publication of ES2065911T3 publication Critical patent/ES2065911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA LA RECUPERACION DE PROTEINAS QUE INCLUYE PROPORCIONAR UNA FUENTE DE CELULAS HUESPED QUE INCORPORAN UNA PROTEINA SINTETIZADA O EXPRESADA, Y UNA FUENTE DE AL MENOS UN TENSIOACTIVO CATIONICO, ANIONICO OANFOTERO Y TRATAR LAS CELULAS HUESPED CON AL MENOS UN TENSIOACTIVO CATIONICO, ANIONICO O ANFOTERO EN CANTIDAD SUFICIENTE PARA EFECTUAR LA SOLUBILIZACION DE LA PROTEINA DESEADA.
ES88305404T 1987-06-15 1988-06-14 Produccion de proteinas en formas activas. Expired - Lifetime ES2065911T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (1)

Publication Number Publication Date
ES2065911T3 true ES2065911T3 (es) 1995-03-01

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88305404T Expired - Lifetime ES2065911T3 (es) 1987-06-15 1988-06-14 Produccion de proteinas en formas activas.

Country Status (14)

Country Link
US (1) US4992531A (es)
JP (1) JPS6447389A (es)
KR (1) KR0126767B1 (es)
CN (1) CN1032425C (es)
AT (1) ATE114156T1 (es)
AU (1) AU609824B2 (es)
CA (1) CA1305284C (es)
DE (1) DE3852116T2 (es)
DK (1) DK322188A (es)
ES (1) ES2065911T3 (es)
IE (1) IE66334B1 (es)
NO (1) NO882635L (es)
NZ (1) NZ225032A (es)
ZA (1) ZA884212B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (ja) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 界面活性剤を用いたタンパク質の新規な精製法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
DE60129432T2 (de) * 2000-05-16 2008-04-17 Bolder Biotechnology, Inc., Louisville Verfahren zur rückfaltung von proteinen mit freien cysteinresten
AU2003267245C1 (en) * 2002-09-20 2008-05-29 Promega Corporation Luminescence-based methods and probes for measuring cytochrome P450 activity
JP2006507818A (ja) * 2002-11-01 2006-03-09 プロメガ　コーポレイション 細胞溶解のための組成物、使用方法、装置およびキット
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
HU229626B1 (hu) * 2005-04-11 2014-03-28 Savient Pharmaceuticals Urát oxidáz változat és alkalmazása
US9534013B2 (en) 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP3312292B1 (en) 2005-05-31 2019-09-25 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US8617531B2 (en) * 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
JP5597200B2 (ja) * 2008-08-18 2014-10-01 プロメガ コーポレイション ルミネッセンスを生じる化合物およびチトクロムｐ４５０３ａ酵素を検出するための方法
GB0901434D0 (en) 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
US9377454B2 (en) 2009-06-25 2016-06-28 Crealta Pharmaceuticals Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
JP2013534909A (ja) * 2010-05-21 2013-09-09 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド 両性イオン性試薬
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
CN107075544B (zh) * 2014-07-22 2021-01-29 生物辐射实验室股份有限公司 与聚合酶联用的缓冲液

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
CA1305284C (en) 1992-07-14
ZA884212B (en) 1989-03-29
DK322188A (da) 1988-12-17
DK322188D0 (da) 1988-06-14
NZ225032A (en) 1991-02-26
AU609824B2 (en) 1991-05-09
ATE114156T1 (de) 1994-12-15
CN88103725A (zh) 1988-12-28
DE3852116D1 (de) 1994-12-22
CN1032425C (zh) 1996-07-31
DE3852116T2 (de) 1995-03-30
NO882635L (no) 1988-12-19
US4992531A (en) 1991-02-12
AU1763288A (en) 1988-12-15
NO882635D0 (no) 1988-06-15
IE66334B1 (en) 1995-12-27
JPS6447389A (en) 1989-02-21
KR900000380A (ko) 1990-01-30
IE881815L (en) 1988-12-15
KR0126767B1 (ko) 1997-12-29

Similar Documents

Publication Publication Date Title
ES2065911T3 (es) Produccion de proteinas en formas activas.
MY101204A (en) Solubilization of protein aggregates
DK183386A (da) Sucralfatsuspension
DK512686A (da) Thrombinpraeparater, deres fremstilling og anvendelse
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
ATE188256T1 (de) Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie
ES2155526T3 (es) Proteinas que se dirigen al interior de viriones de hiv basadas en moleculas de fusion vpr de hiv-1.
DE3852140D1 (de) Produktion von Proteinen in aktiven Formen.
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
FR2662698B1 (es)
BR8707482A (pt) Processo para controle de bioincrustacao em sistema aquoso,composicao biocidamente ativa e composicao
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
EP0315118A3 (en) Dna coding for endothelin and use thereof
DE69524388T2 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
ES2144750T3 (es) Percha.
MY103305A (en) Productions of proteins in active forms
KAUFMAN et al. Protein changes in leaf-sheath pulvini of barley(hordeum) induced by gravistimulation[Abstract Only]
IT8421028V0 (it) Struttura di macchina agricola, in particolare per trattare argini e simili.
KR950032634A (ko) 스트렙토마이세스 써모니트리피컨스 아미노펩티다제를 이용한 천연형 재조합 단백질의 제조방법
IT8025651A0 (it) Procedimento per la fabbricazione di sbozzati adatti, in particolare, per l'occhialeria, e sbozzati ottenuti con taleprocedimento.
ES295383U (es) Mesa desmontable para ordenadores

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295859

Country of ref document: ES